David T. Nash, MD
Advertisement
Articles by David T. Nash, MD
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Administration Anounces Landmark GLP-1 Pricing Agreement with Eli Lilly and Novo Nordisk
2
Wegovy Users More Likely to Reach Key Obesity Treatment Targets, STEP UP Study Finds
3
Oral Semaglutide 25 mg Shows Cardiometabolic Benefits Beyond Weight Loss in OASIS 4 Analysis
4
Lumateperone Gets FDA Nod as Adjunctive Therapy for Major Depressive Disorder
5
